Benzinga's Top Downgrades

Analysts at JP Morgan downgraded ViroPharma

from “overweight” to “neutral.” The target price for ViroPharma has been raised from $45 to $50. ViroPharma's shares closed at $49.42 yesterday. Analysts at Canaccord Genuity downgraded Hologic

from “buy” to “hold.” The target price for Hologic has been lowered to $19. Hologic's shares closed at $22.90 yesterday. Analysts at Macquarie downgraded Symantec

from “outperform” to “neutral.” The target price for Symantec has been lowered to $24. Symantec's shares closed at $23.21 yesterday. UBS downgraded Gogo

from “buy” to “neutral.” Gogo's shares closed at $24.15 yesterday.